$194 Million is the total value of JW Asset Management, LLC's 11 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | $174,342,000 | +0.4% | 3,192,485 | 0.0% | 89.67% | -2.8% | |
| New | INVESCO QQQ TRput | $4,677,000 | – | 17,500 | +100.0% | 2.40% | – | |
| META PLATFORMS INCput | $4,070,000 | -15.9% | 30,000 | 0.0% | 2.09% | -18.6% | ||
| CELH | New | CELSIUS HLDGS INC | $3,673,000 | – | 40,500 | +100.0% | 1.89% | – |
| HZNP | HORIZON THERAPEUTICS PUB L | $3,136,000 | -22.4% | 50,673 | 0.0% | 1.61% | -24.9% | |
| QUIDELORTHO CORP | $1,134,000 | -26.5% | 15,868 | 0.0% | 0.58% | -28.8% | ||
| IDAHO STRATEGIC RESOURCES | $1,031,000 | -39.7% | 217,151 | 0.0% | 0.53% | -41.6% | ||
| MSAC | MEDICUS SCIENCES ACQUISITION | $990,000 | +1.2% | 100,000 | 0.0% | 0.51% | -2.1% | |
| HMCOU | HUMANCO ACQUISITION CORPunit 12/08/2023 | $847,000 | +0.8% | 85,000 | 0.0% | 0.44% | -2.2% | |
| MSOS | ADVISORSHARES TRpure us cannabis | $534,000 | -13.9% | 59,913 | 0.0% | 0.28% | -16.4% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $0 | -100.0% | 11,110 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.